Current Report Filing (8-k)

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 8, 2016

 

 

IMS Health Holdings, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware		001-36381		27-1335689
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

83 Wooster Heights Road

Danbury, CT 06810

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: [phone]

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

---

Item 5.07 Submission of Matters to a Vote of Security Holders.

On April 8, 2016, IMS Health Holdings, Inc. held its 2016 Annual Meeting of Stockholders. At the meeting, stockholders voted on the following items:

Proposal No. 1:  The following nominees were elected by majority vote to serve on the Board of Directors:

 

		For				Against				Abstain				Broker Non-Vote
John G. Danhakl			256,329,619				60,027,889				62,277				4,633,492
Karen L. Katen			307,172,560				9,245,818				1,407				4,633,492
Bryan M. Taylor			257,168,799				59,188,809				62,177				4,633,492

Proposal No. 2: The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2016 was ratified.

 

For		Against		Abstain		Broker Non-Vote
318,884,253		2,152,428		16,596		N/A

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

		IMS Health Holdings, Inc.
Date: April 8, 2016				By:		/s/ Ronald E. Bruehlman
						Name:		Ronald E. Bruehlman
						Title:		Senior Vice President and Chief Financial Officer